Image For Activity Cover
Integrating Screening, Brief Interventions, & Treatment for Stimulant Use Disorder during Buprenorphine Treatment for Opioid Use Disorder in Primary Care
Course Information
Integrating Screening, Brief Interventions, & Treatment for Stimulant Use Disorder during Buprenorphine Treatment for Opioid Use Disorder in Primary Care

The project involves a training series and clinical case discussions specific to the topic of stimulant use disorder screening and interventions in the primary care setting when buprenorphine is being prescribed for OUD.

 

Session 1: Introduction: Stimulant Use in OUD Treatment

Author: Derek Blevins, MD, Assistant Professor of Psychiatry, Columbia University

This webinar will define what a stimulant is as well as explore stimulant pharmacology, stimulant use disorder neurobiology and epidemiology, as well as the impact of stimulant use disorder on physical and mental health and OUD treatment.

 

Session 2: Screening, Diagnosis, and Brief Intervention

Author: Derek Blevins, MD, Assistant Professor of Psychiatry, Columbia University

This webinar will explore the usage of screening tools of varying lengths to evaluate stimulant use, urine drug testing advantages and limitations for patients on MOUD, comprehensive assessment guides, brief intervention strategies and referral conditions, and the role of harm reduction in all levels of care for stimulant use disorder.

 

Session 3: Behavioral Treatment Approaches

Author: Derek Blevins, MD, Assistant Professor of Psychiatry, Columbia University

This webinar will explore how the effectiveness of behavioral treatments, evidence-based behavioral therapies for stimulant use disorder, as well as practical use of behavioral therapies in primary care settings.

 

Session 4: Pharmacologic Treatment Approaches

Derek Blevins, MD, Assistant Professor of Psychiatry, Columbia University

Author: This webinar will explore pharmacologic targets for stimulant use disorder, MOUD and stimulant use disorder, and specific off-label medications for antidepressants, antiepileptics, psychostimulants, anti-craving medications, and medication combinations.

Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
2 Attendance Credits
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
For Buprenorphine Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By